Endymed (Israel) Performance
| ENDY Stock | 325.00 3.00 0.93% |
Endymed has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0666, which means not very significant fluctuations relative to the market. As returns on the market increase, Endymed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Endymed is expected to be smaller as well. Endymed right now shows a risk of 3.41%. Please confirm Endymed downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if Endymed will be following its price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Endymed are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Endymed may actually be approaching a critical reversion point that can send shares even higher in May 2024. ...more
| Begin Period Cash Flow | 7.3 M | |
| Total Cashflows From Investing Activities | 382 K |
Endymed |
Endymed Relative Risk vs. Return Landscape
If you would invest 31,200 in Endymed on January 26, 2024 and sell it today you would earn a total of 1,300 from holding Endymed or generate 4.17% return on investment over 90 days. Endymed is generating 0.1431% of daily returns and assumes 3.4066% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Endymed, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Endymed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Endymed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Endymed, and traders can use it to determine the average amount a Endymed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.042
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ENDY | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.41 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Endymed is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Endymed by adding it to a well-diversified portfolio.
Endymed Fundamentals Growth
Endymed Stock prices reflect investors' perceptions of the future prospects and financial health of Endymed, and Endymed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Endymed Stock performance.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0385 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 13.76 M | |||
| Price To Book | 0.70 X | |||
| Price To Sales | 1.52 X | |||
| Revenue | 21.78 M | |||
| EBITDA | 3.2 M | |||
| Cash And Equivalents | 5.02 M | |||
| Cash Per Share | 0.39 X | |||
| Total Debt | 463 K | |||
| Debt To Equity | 7.10 % | |||
| Book Value Per Share | 1.04 X | |||
| Cash Flow From Operations | 4.63 M | |||
| Earnings Per Share | 0.74 X | |||
| Total Asset | 19.6 M | |||
| Retained Earnings | (12 M) | |||
| Current Asset | 9 M | |||
| Current Liabilities | 4 M | |||
About Endymed Performance
To evaluate Endymed Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Endymed generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Endymed Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Endymed market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Endymed's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.Things to note about Endymed performance evaluation
Checking the ongoing alerts about Endymed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Endymed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Endymed had very high historical volatility over the last 90 days | |
| About 58.0% of the company shares are held by company insiders |
- Analyzing Endymed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Endymed's stock is overvalued or undervalued compared to its peers.
- Examining Endymed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Endymed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Endymed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Endymed's stock. These opinions can provide insight into Endymed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Endymed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Endymed Stock analysis
When running Endymed's price analysis, check to measure Endymed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endymed is operating at the current time. Most of Endymed's value examination focuses on studying past and present price action to predict the probability of Endymed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endymed's price. Additionally, you may evaluate how the addition of Endymed to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |